av/jubilant-life-sciences--big.svg

COM:JUBILANTPHARMOVA

Jubilant Pharmova

  • Stock

Last Close

1,254.55

08/11 10:00

Market Cap

115.38B

Beta: -

Volume Today

137.85K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
57.22B
-
57.76B
0.95%
57.00B
1.31%
57.65B
1.14%
74.25B
28.78%
89.97B
21.18%
89.77B
0.23%
59.64B
33.56%
60.59B
1.60%
62.19B
2.64%
67.03B
7.78%
cost of revenue
26.87B
-
29.18B
8.61%
23.71B
18.76%
22.52B
5.01%
31.44B
39.58%
38.21B
21.56%
34.54B
9.60%
17.53B
49.24%
17.87B
1.91%
18.78B
5.09%
47.39B
152.33%
gross profit
30.35B
-
28.58B
5.83%
33.30B
16.51%
35.13B
5.51%
42.81B
21.87%
51.76B
20.90%
55.22B
6.69%
42.10B
23.75%
42.72B
1.47%
43.41B
1.62%
19.64B
54.75%
selling and marketing expenses
1.61B
-
1.28B
20.21%
1.20B
6.30%
1.33B
10.70%
1.96B
47.03%
2.18B
11.18%
2.32B
6.53%
1.49B
35.72%
1.56B
4.61%
1.53B
2.10%
general and administrative expenses
1.06B
-
1.24B
16.99%
971.38M
21.40%
1.02B
5.34%
1.46B
42.60%
2.68B
83.39%
2.46B
7.89%
2.32B
5.77%
2.46B
5.83%
2.23B
9.24%
selling general and administrative expenses
2.67B
-
2.52B
5.47%
2.17B
13.70%
2.35B
8.31%
3.42B
45.11%
4.85B
42.01%
4.78B
1.42%
3.81B
20.29%
4.02B
5.35%
3.76B
6.47%
14.45B
284.69%
research and development expenses
202.20M
-
185.05M
8.48%
other expenses
113.58M
-
134.08M
18.05%
109.04M
18.68%
159.32M
46.11%
226.88M
42.41%
125.48M
44.69%
115.14M
8.24%
67.18M
41.65%
86.90M
29.35%
383.30M
341.08%
cost and expenses
49.94B
-
53.74B
7.61%
47.60B
11.43%
46.92B
1.42%
63.17B
34.64%
76.15B
20.54%
74.89B
1.66%
48.45B
35.30%
52.35B
8.04%
59.97B
14.56%
61.84B
3.12%
operating expenses
23.07B
-
24.55B
6.45%
23.89B
2.71%
24.40B
2.14%
31.74B
30.08%
37.94B
19.53%
40.34B
6.34%
30.92B
23.36%
34.48B
11.51%
41.19B
19.47%
14.45B
64.91%
interest expense
3.06B
-
3.27B
6.71%
3.42B
4.72%
3.01B
12.14%
2.64B
12.14%
2.06B
22.05%
2.73B
32.37%
1.73B
36.43%
1.38B
20.26%
1.88B
36.14%
2.72B
44.69%
ebitda
10.08B
-
6.82B
32.34%
12.64B
85.27%
13.36B
5.70%
15.33B
14.72%
17.75B
15.79%
19.83B
11.70%
15.21B
23.27%
11.54B
24.16%
8.27B
28.33%
9.01B
8.95%
operating income
7.28B
-
4.02B
44.73%
9.41B
133.77%
10.73B
14.09%
11.07B
3.18%
13.82B
24.80%
12.39B
10.37%
11.44B
7.63%
8.40B
26.60%
3.75B
55.36%
5.19B
38.42%
depreciation and amortization
2.81B
-
2.88B
2.41%
3.46B
20.15%
2.91B
15.78%
4.15B
42.43%
3.71B
10.64%
4.62B
24.54%
4.52B
2.23%
3.82B
15.49%
5.54B
45.15%
3.82B
31.07%
total other income expenses net
-5.21B
-
-3.62B
30.47%
-3.56B
1.57%
-3.36B
5.83%
-2.48B
26.00%
-4.78B
92.56%
-2.26B
52.77%
-2.73B
20.95%
-2.09B
23.35%
-3.47B
65.77%
-3.73B
7.32%
income before tax
2.07B
-
403.24M
80.55%
5.84B
1,349.11%
7.38B
26.24%
8.59B
16.46%
9.04B
5.21%
12.11B
33.94%
8.71B
28.04%
6.30B
27.62%
277.80M
95.59%
1.46B
427.00%
income tax expense
696.44M
-
804.84M
15.56%
1.53B
89.92%
1.63B
6.65%
2.25B
37.82%
3.27B
45.46%
3.12B
4.44%
2.97B
4.83%
2.17B
26.84%
926.60M
57.38%
978M
5.55%
net income
1.09B
-
-577.64M
152.98%
4.31B
846.98%
5.76B
33.41%
6.43B
11.67%
5.74B
10.63%
8.98B
56.36%
8.36B
6.94%
4.14B
50.48%
-609.80M
114.73%
771M
226.43%
weighted average shs out
159.28M
-
159.13M
0.10%
156.14M
1.88%
155.87M
0.17%
155.84M
0.02%
155.86M
0.01%
159.28M
2.19%
159.27M
0.01%
159.17M
0.06%
159.15M
0.02%
weighted average shs out dil
159.28M
-
159.28M
0%
156.22M
1.92%
155.96M
0.17%
155.84M
0.08%
155.86M
0.01%
159.28M
2.19%
159.27M
0.01%
159.17M
0.06%
159.15M
0.02%
eps
6.85
-
-3.63
152.99%
25.10
791.46%
36.93
47.13%
41.25
11.70%
36.86
10.64%
56.39
52.98%
52.48
6.93%
26.01
50.44%
-3.83
114.73%
4.87
227.15%
epsdiluted
6.85
-
-3.63
152.99%
25.08
790.91%
36.91
47.17%
41.25
11.76%
36.86
10.64%
56.39
52.98%
52.48
6.93%
26.01
50.44%
-3.83
114.73%
4.86
226.89%

All numbers in (except ratios and percentages)